Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sensi-IP + sodium fluoride is a **combination toothpaste formulation** used in the management of **dentinal hypersensitivity** and **prevention of dental caries**. The product incorporates **Sensi-IP**, an ingredient designed to reduce dentin hypersensitivity, together with **sodium fluoride**, a well-established agent for preventing dental caries by promoting remineralization and inhibiting demineralization of tooth enamel. The precise composition of Sensi-IP is not detailed in the available clinical trial data; however, the combination is studied in clinical settings as a single toothpaste product for sensitivity relief and dental health maintenance. Mechanistically, sodium fluoride acts by enhancing the resistance of teeth to acid-induced demineralization and promoting the remineralization of early carious lesions. Sensi-IP is used for its desensitizing properties, likely through occlusion of exposed dentinal tubules or nerve modulation[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sensi-IP + sodium fluoride.